prof. dr. Anje Cauwels

Journal Article
A1
open access

High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma

Willem Daneels (UGent) , Alexander Van Parys (UGent) , Leander Huyghe (UGent) , Elke Rogge (UGent) , Steffi De Rouck (UGent) , Ruben Christiaen, Lennart Zabeau (UGent) , Sylvie Taveirne (UGent) , Jo Van Dorpe (UGent) , Niko Kley, et al.

(2024) EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 13(1).

Add to list

Journal Article
A1
open access

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

Sandra Van Lint (UGent) , Alexander Van Parys (UGent) , Bram Van Den Eeckhout (UGent) , Niels Vandamme (UGent) , Stephane Plaisance, Annick Verhee (UGent) , Dominiek Catteeuw (UGent) , Elke Rogge (UGent) , Jennifer De Geest (UGent) , Nele Vanderroost (UGent) , et al.

(2023) MOLECULAR CANCER. 22(1).

Add to list

Journal Article
A1
open access

Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia

Steven Goossens (UGent) , Anje Cauwels (UGent) , Tim Pieters (UGent) , Renate De Smedt (UGent) , Sara T'Sas (UGent) , André Pedro Pinto De Almeida (UGent) , Willem Daneels (UGent) , Pieter Van Vlierberghe (UGent) and Jan Tavernier (UGent)

(2022) HAEMATOLOGICA. 107(6). p.1448-1453

Add to list

Journal Article
A1
open access

Microcirculatory function during endotoxemia : a functional citrulline-arginine-NO pathway and NOS3 complex is essential to maintain the microcirculation

Karolina A. P. Wijnands, Dennis M. Meesters, Benjamin Vandendriessche (UGent) , Jacob J. Briede, Hans M. H. van Eijk, Peter Brouckaert (UGent) , Anje Cauwels (UGent) , Wouter H. Lamers and Martijn Poeze

(2021) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 22(21).

Add to list

Journal Article
A1
open access

Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Elke Rogge, Annick Verhee (UGent) , Bram Van Den Eeckhout (UGent) , Shengru Pang, Marco Prinz, Niko Kley, Gilles Uze and Jan Tavernier (UGent)

(2021) SCIENTIFIC REPORTS. 11(1).

Add to list

Journal Article
A1
open access

Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication

Bram Van Den Eeckhout (UGent) , Leander Huyghe (UGent) , Sandra Van Lint (UGent) , Elianne Burg (UGent) , Stéphane Plaisance, Frank Peelman (UGent) , Anje Cauwels (UGent) , Gilles Uzé, Niko Kley, Sarah Gerlo (UGent) , et al.

(2021) JOURNAL FOR IMMUNOTHERAPY OF CANCER. 9(11).

Add to list

Journal Article
A1
open access

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, Thomas Ertveldt, Lien De Beck, Hannelore Ceuppens, Katrijn Broos, Yannick De Vlaeminck, Cleo Goyvaerts, Magali Verdonck, et al.

(2021) MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT. 22. p.172-182

Add to list

Conference Paper
C3
open access

Teaching an old dog new tricks : activity-on-target interferon to treat T-cell acute lymphoblastic leukemia

Steven Goossens (UGent) , Anje Cauwels (UGent) , Tim Pieters (UGent) , Willem Daneels (UGent) , Pieter Van Vlierberghe (UGent) and Jan Tavernier (UGent)

(2020) EHA25 Virtual - The European Hematology Association, Abstracts.

Add to list

Journal Article
A1
open access

Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies

Leander Huyghe (UGent) , Alexander Van Parys (UGent) , Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Stijn De Munter (UGent) , Jennyfer Bultinck (UGent) , Lennart Zabeau (UGent) , Jeroen Hostens, An Goethals, Nele Vanderroost (UGent) , et al.

(2020) EMBO MOLECULAR MEDICINE. 12(2).

Add to list

Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Dominiek Catteeuw (UGent) , Shengru Pang, Franciane Paul, Elke Rogge (UGent) , Annick Verhee (UGent) , Marco Prinz, Niko Kley, Gilles Uzé, et al.

(2019) JOURNAL OF AUTOIMMUNITY. 97. p.70-76

Academic Bibliography

prof. dr. Anje Cauwels

High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia

Microcirculatory function during endotoxemia : a functional citrulline-arginine-NO pathway and NOS3 complex is essential to maintain the microcirculation

Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE

Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

Teaching an old dog new tricks : activity-on-target interferon to treat T-cell acute lymphoblastic leukemia

Safe eradication of large established tumors using neovasculature-targeted tumor necrosis factor-based therapies

Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice

Contents

Support

Contact